Dallas,
TX: ReportsandReports announce it will carry Bronchitis – Drug Pipeline Analysis and Market Forecasts to 2016,Market Research Report in its Store.
Browse the complete Report on: http://www.reportsandreports.com/market-reports/bronchitis-drug-pipeline-analysis-and-market-forecasts-to-2016/
Bronchitis – Drug Pipeline Analysis and Market Forecasts to 2016
Summary
GlobalData’s pharmaceutical and healthcare report offering, “Bronchitis – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global bronchitis market. The report identifies the key trends shaping and driving the global bronchitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global bronchitis sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
The global bronchitis market was valued at $482m in 2009 and is forecast to grow by 3.7% annually for the next seven years. The typical form of bronchitis is self-limited. The bronchitis market is characterized by many generics and OTC. The NSAIDS, cough suppressants and antipyretics are mere supportive therapies. Antibiotics are highly prescribed to treat atypical form of the disease. The increase in the market size is attributed to the increase in incidence and increase in the up take of cost effective drugs
There are 13 molecules in the various phases of the developmental pipeline. Of these, only five are in Phase III and the rest are in the early stages of development. The pipeline consists of no new antibiotics. The antibiotics in the pipeline are generic. Upon approval they will add to the competition. The phase of the pipeline consists of levefloxacin and Merck’s Singulair. Upon approval they are expected to intensify the competition
Scope
The scope of the report includes:
– Annualized global bronchitis market revenues data from 2001 to 2009, forecast for seven years to 2016.
– Geographies covered in this report are the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France, and Japan.
– Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include alpha 1 adrenergic receptors agonist, beta (2)-adrenergic agonist,, anti-inflammatory, inhibitor topoisomerase IV DNA gyrase, glucocorticoid agonist leukotriene D4 antagonist and loop diuretic
– Analysis of the current and future market competition in the global bronchitis market. The key market players covered are Merck and Co and Johnson & Johnson Pharmaceutical Research & Development, Pfizer and Merck & Co.
– Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
– Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future bronchitis market.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
– Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
– Develop business strategies by understanding the trends shaping and driving the global bronchitis market.
– Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global bronchitis market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
– What’s the next big thing in the global bronchitis market landscape? – Identify, understand and capitalize.
Browse:- http://www.reportsandreports.com/market-reports/bronchitis-drug-pipeline-analysis-and-market-forecasts-to-2016/
Table of Content
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Global Bronchitis: Market Characterization 5
2.1 Overview 5
2.1.1 Treatment Options 6
2.2 Bronchitis Market Size 6
2.3 Bronchitis Market Forecast and CAGR 6
2.4 Drivers and Barriers for the Bronchitis Market 8
2.4.1 Drivers for the Bronchitis Market 8
2.4.2 Barriers for the Bronchitis Market 9
2.5 Opportunity and Unmet Need 9
2.6 Key Takeaway 10
3 Global Bronchitis Market: Competitive Assessment 11
3.1 Overview 11
3.2 Strategic Competitor Assessment 11
3.3 Product Profile for the Major Marketed Products in the Bronchitis Market 11
3.3.1 Antivirals 11
3.3.2 Antibiotics 12
3.3.3 Analgesics and NSAID 13
3.4 Key Takeaway 14
4 Global Bronchitis Market: Pipeline Assessment 15
4.1 Overview 15
4.2 Strategic Pipeline Assessment 15
4.3 Bronchitis Market – Promising Drugs under Clinical Development 17
4.4 Product Profiles of the Most Promising Products in Bronchitis Market 17
4.4.1 Dexamethasone 17
4.4.2 Levofloxacin 18
4.4.3 Furosemide 19
4.4.4 Montelukast sodium 19
4.5 Bronchitis Market – Clinical Pipeline by Mechanism of Action 20
4.5.1 Bronchitis Disease – Phase III Clinical Pipeline 21
4.5.2 Bronchitis Disease – Phase II Clinical Pipeline 21
4.5.3 Bronchitis – Phase I Clinical Pipeline 21
4.6 Key Takeaway 21
5 Global Bronchitis Market: Implications for Future Market Competition 22
6 Global BMarket: Future Players 23
6.1 Introduction 23
6.2 Merck & Co., Inc 23
6.2.1 Company Overview 23
6.2.2 Business Description 24
6.2.3 Respiratory Disease Pipeline Product Portfolio 25
6.3 Pfizer Inc. 25
6.3.1 Company Overview 25
6.3.2 Business Description 25
6.3.3 Respiratory Disease Pipeline Product Portfolio 27
6.4 Abbott Laboratories 27
6.4.1 Company Overview 27
6.4.2 Business Description 27
6.4.3 Respiratory Disease Pipeline Product Portfolio 28
6.5 Johnson & Johnson 29
6.5.1 Company Overview 29
6.5.2 Business Description 29
6.5.3 Respiratory Disease Pipeline Product Portfolio 30
7 Bronchitis disease Market: Appendix 31
7.1 Definitions 31
7.2 Acronym 31
7.3 Research Methodology 32
7.3.1 Coverage 32
7.3.2 Secondary Research 33
7.3.3 Forecasting 33
7.3.4 Primary Research 36
7.3.5 Expert Panels 36
7.4 Contact Us 36
7.5 Disclaimer 36
7.6 Sources 37
Related Reports:
http://www.reportsandreports.com/market-reports/acne-drug-pipeline-analysis-and-market-forecasts-to-2016/
http://www.reportsandreports.com/market-reports/anemia-drug-pipeline-analysis-and-market-forecasts-to-2016/http://www.reportsandreports.com/market-reports/stomach-cancer-drug-pipeline-analysis-and-market-forecasts-to-2/
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
